Results

Total Results: 1,108 records

Showing results for "executive".

321. Disposition of Comments for CERs 155 156 Contast-Induced Nephropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
     January 07, 2016 - To acknowledge this limitation, we added the following text to the Discussion section of the executive … We revised the abstract, executive summary, and main report to be consistent with the final results … We revised the statement in the executive summary and Discussion to read: “Also, patients with risk … Summary The Executive Summary is a good high-level view of the document, and highlights overall … We revised the text in the Executive Summary, Introduction and Discussion sections to clarify that

322. Disposition of Comments for Treatment Strategies for Patients With Peripheral Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_disposition-comments.pdf
     May 29, 2013 - Executive Summary Well done. … Hiatt, William Executive Summary The statement "In symptomatic and asymptomatic PAD patients (92% IC … David Executive Summary A serious ommission is that the importance of lifestyle modification (smoking … The introduction is abbreviated in the Executive Summary due to word limits. … The Executive Summary is available as a more concise version of this report.

323. Assessing the Impact of Indexing Performance Measure Codes on the Perceived Value of EPC Reports to Health Systems (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-assessing-impact.pdf
     September 01, 2018 - The second contained page numbers in the report’s executive summary where those quality measures are … The second table contained the pages in the reports executive summary where those quality measures … If they perceive the title of the report to be of relevance, they will then read the executive summary … Use the executive summary of the EPC report without the hyperlinked quality measure index to find the … answer in the executive summary and record how long it takes.

324. Disposition of Comments for Screening of Methicillin-Resistant Staphylococcus Aureus (MRSA) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_disposition-comments.pdf
     January 01, 2010 - Summary Executive Summary: I feel recommendations by AHRQ at a minimum should state the following … Reviewer #6 (Peer) Intro/ES Introduction Executive Summary: [page ES-1, lines 16-19] The sentence … The interventions should be included in Table ES-1 of the executive summary. … The Executive Summary (page ES- 10) cites these 3 studies as addressing KQ3A. … Reviewer #6 (Peer) Discussion/ Conclusion Discussion/ Conclusion Executive Summary: 15.

325. Disposition of Comments for Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-disposition-comments-naloxone.pdf
     November 27, 2017 - This should be stated in the Executive Summary as well. … The report was summarized in an Executive Summary as well as in an Abstract and Key Messages. … A condensed Executive Summary should be considered. … The Executive Summary may be a bit long (12 pages of text vs 30 pages in the main report). … Peer Reviewer #4 Executive Summary ES-10 34 Agree with limitations section.

326. Comparative Effectiveness and Safety of Analgesics for Osteoarthritis—An Update of the 2006 Report. (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-disposition-120516.pdf
     October 01, 2011 - Peer Reviewer #4 Executive Summary p. 20, Duration of NSAID use: It is misleading to say there … The sentence in question in the Executive Summary is referring to the finding in meta-analysis that … Summary Executive Summary provides good overall outline of the project. … Peer Reviewer #5 Executive Summary p. … We also revised the Executive Summary introduction accordingly (top of page 10).

327. Disposition of Comments Report for Evidence Report/Technology Assessment No. 214 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/smoking-pregnancy-infants_disposition-comments.pdf
     February 25, 2014 - Reviewer 4 (TEP) Executive Summary Background ES1: rates are presented as accurate/valid. … We have inserted a statement in the Background section of the Executive Summary noting the range of … Reviewer 10 (TEP) Executive Summary Page 10 - ES-2 line 45: Question 1- Quitting smoking while … Reviewer 10 (TEP) Executive Summary Page 9 - ES-1 line 16: “complications for both the pregnant … It is too long The Executive Summary was prepared according to the AHRQ EPC template.

328. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_executive.pdf
     February 01, 2006 - emission tomography (PET) Effectiveness of Noninvasive Diagnostic Tests for Breast Abnormalities Executive … Full Report This executive summary is part of the following document: Bruening W, Launders J, Pinkney … More Copies For more copies of Effectiveness of Noninvasive Diagnostic Tests for Breast Abnormalities: Executive

329. Disposition of Comments for Pressure Ulcer Treatment Strategies: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_disposition-comments.pdf
     May 08, 2013 - There is a concern, however, that the results in the Structured Abstract/Executive Summary will be … Reviewer: 9 Executive summary Page 27, line 36, should this read "did not describe harm" Thank you … Reviewer: 9 Executive summary In page 6, line 18 the search is up to August 5 2011, whereas in page … Anonymous comments based on American Association of Wound Care (AAWC) Guidelines Executive … Catherine Ratliff Executive summary Nice job Thank you, we appreciate the feedback.

330. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
     March 01, 2017 - Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia Executive … evidence for vitamin B12 (0.02=0.5 mg), B6 (3-10 mg), and folate (0.56-1 mg) shows no benefit for executive … • Low-strength evidence shows a small, 6-month improvement in executive/attention/ processing speed … • Low-strength evidence shows no benefit on brief cognitive test performance, executive/attention/ … Full Report This executive summary is part of the following document: Kane RL, Butler M, Fink HA, Brasure

331. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
     March 01, 2017 - Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia Executive … evidence for vitamin B12 (0.02=0.5 mg), B6 (3-10 mg), and folate (0.56-1 mg) shows no benefit for executive … • Low-strength evidence shows a small, 6-month improvement in executive/attention/ processing speed … • Low-strength evidence shows no benefit on brief cognitive test performance, executive/attention/ … Full Report This executive summary is part of the following document: Kane RL, Butler M, Fink HA, Brasure

332. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
     June 01, 2010 - Executive Summary See my comments above regarding key messages. … Executive Summary Page 19. … Executive Summary Key Question 2. … This conclusion is wrong for several reasons: Executive Summary L. … This has been clarified in the Executive Summary.

333. Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-2007/research
     November 19, 2007 - Document PDF 787.7 KB Related Files Download Full Report Appendixes [PDF · 1.1 MB] Download Executive

334. Disposition of Comments for Progestogens for Prevention of Preterm Birth (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth-disposition-121205.pdf
     September 07, 2012 - Thank you Peer Reviewer #2 Executive Summary Page 15: Regarding the executive summary, the authors … Peer Reviewer #2 Executive Summary Page 17: In the Summary Strength of Evidence and Findings, the … Peer Reviewer #3 Executive Summary Page 13, Line 51This sentence was confusing. … Peer Reviewer #4 Executive Summary Comment should 17ohp alone be assessed? … Abstract, executive summary, and subsequent articles will be of more use.

335. Disposition of Comments for Migraine in Adults: Preventive Pharmacologic Treatments (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
     April 18, 2013 - The executive summaries are posted on line in the AHRQ website with links to the full reports. 2. … The executive summary has restricted reference number. … The posted on line executive summary provides concise summary statements. … Reviewer 3 Children report, the Executive Summary, Discussion: “Moreover, two other antiepileptic … adf adg Part A: Executive Summary Nice overview of the information.

336. Disposition of Comments for CER 182 Glasgow Coma Scale (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/field-triage-glascow-disposition-170415.pdf
     January 12, 2017 - TEP Reviewer #3 Introduction My opinion is that the executive summary is a bit burdensome to read. … The Executive Summary summarizes the report, including background, methods, results, and conclusions … TEP Reviewer #3 Introduction Executive Summary / Scope of Review and Key Questions line 47-48. … TEP Reviewer #3 Introduction Executive summary – Risk of Bias Assessment of Individual Studies – why … In the final report, the Results in the Executive Summary are bulleted.

337. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
     December 01, 2015 - Summary Table Conclusions From CER Executive Summary Literature Analysis (July 2015) FDA Boxed … Conclusions From CER Executive … Conclusions From CER Executive … Conclusions From CER Executive … G-19 Conclusions From CER Executive Summary Literature Analysis

338. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
     December 01, 2015 - Summary Table Conclusions From CER Executive Summary Literature Analysis (July 2015) FDA Boxed … Conclusions From CER Executive … Conclusions From CER Executive … Conclusions From CER Executive … G-19 Conclusions From CER Executive Summary Literature Analysis

339. AHRQ Slide Template
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-pain-management-grand-rounds-slides.pptx
     March 01, 2022 - Management, Graduate School of Public Health Lisa Simpson, M.B., B.Ch., M.P.H., FAAP President and Chief Executive … Agenda Nicole Hemmenway Chief Executive Officer – U.S. Pain Foundation Bernard J. … Nicole Hemmenway Chief Executive Officer – U.S. Pain Foundation Bernard J. … Technical Expert Panel Members EPC Program Associate Editor Peer Reviewers Nicole Hemmenway Chief Executive … Chan School of Public Health General Moderated Discussion and Q & A Nicole Hemmenway Chief Executive

340. Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/asthma-immunotherapy-2010/research
     March 27, 2013 - Download Main Document PDF 4.7 MB Related Files Download Full Report [PDF · 4.7 MB] Download Executive … In the Results section of the executive summary, in the section regarding subcutaneous versus sublingual